Clinical Trials Sponsored by Jennifer Eva Selfridge

Total 4 results

Jennifer Eva Selfridge

Recruiting

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Colorectal Cancer | Hodgkin Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Plasma Cell Myeloma | Hematologic Malignancy | Rectum Cancer | Myeloproliferative Syndrome

United States
Jennifer Eva Selfridge

Not yet recruiting

Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma

Siewert Type II Adenocarcinoma of Esophagogastric Junction | Adenocarcinoma Esophagus | Siewert Type I Adenocarcinoma of Esophagogastric Junction | Locally Advanced Adenocarcinoma
Jennifer Breel

Recruiting

Towards a Sex-specific "Female Enhanced Recovery After Cardiac Surgery'' (F-ERAS) Pathway: (F-ERAS)

Female | Male | Surgery,Cardiac

Netherlands
Jennifer Breel
Noordwest Ziekenhuisgroep; Rijnstate Hospital; Diakonessenhuis, Utrecht; Alrijne...

Completed

The Pain Suppressive Effect of Alternative Spinal Cord Stimulation Frequencies (HALO)

Neuropathic Pain | Failed Back Surgery Syndrome

Netherlands

3

Subscribe